“…In a series of recent reports our laboratory has demonstrated the diagnostic and therapy potential of these ORFs, termed the "Dark Matter" of the human proteome, in diverse therapeutic areas including cancer, diabetes and neurodegenerative diseases [25,26,40]. Hypothesizing that these novel proteins may offer new molecular entities to further Ebola virus research, a comprehensive analysis of the ORFs was undertaken (Table 2 Included as supplementary).…”